GSK to produce 60 million Novavax doses for Britain
New computational models to understand colon cancer
29 March 2021New technique provides detailed map of lung pathology in COVID-19
29 March 2021GSK to produce 60 million Novavax doses for Britain
GlaxoSmithKline is to manufacture 60 million doses of the COVID-19 vaccine developed by US biotech company Novavax for UK distribution, the British pharmaceutical giant said in a statement Monday.
